Hydroxocobalamin Orion

Hydroxocobalamin, the active ingredient in Hydroxocobalamin Orion, is a vitamin B12 (cobalamin) presented as an injectable solution for intramuscular use. It is employed to correct vitamin B12 deficiency and related hematologic disorders in patients of all ages. The formulation provides rapid bioavailability, allowing efficient replenishment of intracellular cobalamin stores. It is indicated when oral supplementation is insufficient or absorption is impaired.

GNH USA supplies Hydroxocobalamin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Hydroxocobalamin is used to treat conditions related to vitamin B12 deficiency, supporting normal hematopoiesis and neurological function.

Vitamin B12 deficiency: restores normal B12 levels, improves anemia and neurological symptoms. Pernicious anemia: provides the necessary cofactor for DNA synthesis, correcting ineffective erythropoiesis. Megaloblastic anemia due to B12 deficiency: normalizes red blood cell size and reduces hypersegmented neutrophils.

Injection of hydroxocobalamin may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Injection site pain: mild soreness at the injection site. - Redness or swelling: localized erythema or edema. - Headache: transient headache after administration.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical care. - Hypotension: sudden drop in blood pressure. - Severe skin reactions: such as Stevens‑Johnson syndrome.

Hydroxocobalamin should be used with appropriate clinical oversight to minimise risks.

Assess B12 status: confirm deficiency before initiating therapy. Monitor hematologic response: check hemoglobin and MCV periodically. Evaluate for cyanide exposure: hydroxocobalamin also binds cyanide; consider in relevant cases. Use with caution in renal impairment: adjust monitoring as needed. Avoid intravascular injection: ensure proper intramuscular technique. Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Hydroxocobalamin may interact with other medicines that affect cobalamin metabolism or absorption.

Major Interactions (Avoid): - Metformin: may mask B12 deficiency, requiring closer monitoring. - Proton pump inhibitors: reduce oral B12 absorption, but injectable form less affected; still monitor levels.

Moderate Interactions (Monitor Closely): - Nitrous oxide anesthesia: can inactivate B12, increasing need for supplementation. - Anticonvulsants (e.g., phenytoin, carbamazepine): may increase B12 requirements. - Folate supplements: high doses may mask hematologic signs of B12 deficiency.